Evidence map›Paper›PMID 31670856›Full record

ArticleGlia2020

Developmental stage-specific role of Frs adapters as mediators of FGF receptor signaling in the oligodendrocyte lineage cells.

Miki Furusho, Akihiro Ishii, Jean M Hebert, Rashmi Bansal

Open access · greenAbstract read
In one paragraph

Article in Glia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Miki FurushoDepartment of Neuroscience, University of Connecticut Medical School, Farmington, Connecticut.
Akihiro IshiiDepartment of Neuroscience, University of Connecticut Medical School, Farmington, Connecticut.
Jean M HebertDepartment of Neuroscience, Albert Einstein College of Medicine, Bronx, New York.
Rashmi BansalDepartment of Neuroscience, University of Connecticut Medical School, Farmington, Connecticut.ORCID 0000-0002-9122-4899
University of Connecticut · USAlbert Einstein College of Medicine · US

Funding

Fibroblast Growth Factor Receptors in Myelin Function and DiseaseR01NS038878 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI BANSAL, RASHMI · 1999 to 2012
$3.9M
Genetic Analysis of Forebrain Patterning & NeurogenesisR01MH070596 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HEBERT, JEAN M · 2006 to 2017
$3.9M
Role of FGF-Signaling in MyelinogenesisR37NS038878 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI BANSAL, RASHMI · 2013 to 2019
$2.9M
Foundation for the National Institutes of Health 5R37NS038878NIMH NIH HHS R01 MH070596NINDS NIH HHS R01 NS038878NINDS NIH HHS R37 NS038878
6 · The paper itself

Abstract

FGF signaling is important for numerous cellular processes and produces diverse cellular responses. Our recent studies using mice conditionally lacking FGF-Receptor-1 (Fgfr1) or Fgfr2 during different stages of myelinogenesis revealed that Fgfr signaling is first required embryonically for the specification of oligodendrocyte progenitors (OPCs) and then later postnatally for the growth of the myelin sheath during active myelination but not for OPC proliferation, differentiation, or ensheathment of axons. What intracellular signal transduction pathways are recruited immediately downstream of Fgfrs and mediate these distinct developmentally regulated stage-specific responses remain unclear. The adapter protein Fibroblast-Growth-Factor-Receptor-Substrate-2 (Frs2) is considered a key immediate downstream target of Fgfrs. Therefore, here, we investigated the in vivo role of Frs adapters in the oligodendrocyte lineage cells, using a novel genetic approach where mice were engineered to disrupt binding of Frs2 to Fgfr1 or Fgfr2, thus specifically uncoupling Frs2 and Fgfr signaling. In addition, we used conditional mutants with complete ablation of Frs2 and Frs3. We found that Frs2 is required for specification of OPCs in the embryonic telencephalon downstream of Fgfr1. In contrast, Frs2 is largely dispensable for transducing Fgfr2-mediated signals for the growth of the myelin sheath during postnatal myelination, implying the potential involvement of other adapters downstream of Fgfr2 for this function. Together, our data demonstrate a developmental stage-specific function of Frs2 in the oligodendrocyte lineage cells. This contextual requirement of adapter proteins, downstream of Fgfrs, could partly explain the distinct responses elicited by the activation of Fgfrs during different stages of myelinogenesis.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell DifferentiationCell LineageCells, CulturedFibroblast Growth FactorsMyelin SheathOligodendrogliaReceptor, Fibroblast Growth Factor, Type 1Signal TransductionAdaptor Proteins, Signal TransducingFibroblast Growth FactorsReceptor, Fibroblast Growth Factor, Type 1myelinmyelinationmyelinogenesisoligodendrocyteoligodendroglia

Identifiers

PMID31670856
PMCPMC8353651
OpenAlexW2986910456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.